ArticleMolecular cancer therapeutics2018

Targeting the Mevalonate Pathway Suppresses VHL-Deficient CC-RCC through an HIF-Dependent Mechanism.

Jordan M Thompson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.